Kevin H Rhodes

3M Chief Legal Officer sells 7,669 shares at $171.20; retains 43,779 shares post-transaction

Kevin H Rhodes, EVP and Chief Legal Officer, sold 7,669 shares of 3M (MMM) at $171.20 on 2026-07-22, reducing his non-derivative holdings by 14.9%. His cross-ticker track record shows a 100.00% well-timed sell rate across 2 prior sales with an average 90-day return of -4.6%, and at MMM specifically, both of his 2 prior sales (on 2025-05-20 and 2025-01-27) preceded subsequent declines at the 90-day mark. The sale occurred at $171.20, near the 52-week high of $177.41 (only 4.4% below peak) and ahead of a strong recent run (+4.8% over 30 days, +16.2% over 90 days). The insider retains a substantial non-derivative stake of 43,779 shares, indicating a partial reduction rather than an exit. His insider position remains material given 3M's enterprise scale ($87.5B market cap, $6.5B quarterly revenue, P/E of 29.19).

EVP Kevin H Rhodes sold 7,976 shares of MMM at $154.02; holding -34.5%, well-timed vs. prior MMM trade; revenue down -24.8% YoY

Rhodes sold 7,976 shares (approximately 34.5% of pre-transaction holdings) at $154.02, reducing his stake from 23,123 to 15,147 shares. His prior sell at this ticker on 2025-01-27 showed a 90-day decline of -8.4%, establishing a pattern of well-timed exits at MMM. The current context is material: 3M's annual revenue declined -24.8% year-over-year, signaling significant operational contraction. While the current stock price of $149.40 is 3.7% below the 52-week high of $155.12, the transaction at $154.02 captured near-peak valuation levels before the subsequent decline. The combination of substantial shareholding reduction and a fundamental revenue deterioration warrant attention to whether this reflects heightened insider caution regarding near-term business trajectory.

EVP Rhodes sells 6,743 shares of 3M (MMM) at $149.85; holdings shrink 57.9% amid -4.5% annual revenue decline and full-year losses.

Kevin Rhodes, Chief Legal Officer and Secretary at 3M, executed a substantial liquidation on 2025-01-27, selling 6,743 shares at $149.85 for $1,010,415.62, reducing his shareholdings from 11,645 shares to 4,902 shares—a 57.9% reduction. This sale occurs in a context where the company faced significant headwinds: full-year net income was negative, annual revenue declined 4.5%, and the company reported only $1.4B net income against $6.3B in latest quarterly revenue while carrying a P/E of 18.78. The magnitude of the position reduction—nearly 58% of holdings—alongside 3M's negative full-year profitability and revenue contraction suggests material reassessment of shareholding priorities at the executive level.